Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Adipose Derived Regenerative Cells (ADRCs) From Excess Tissue and Cells Designated for Discard From Patients With Chronic Heart Disease

NCT02732106 is registered in ClinicalTrials.gov with Cytori Therapeutics as lead sponsor.

NCT NCT02732106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02732106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Adipose Derived Regenerative Cells (ADRCs) From Excess Tissue and Cells Designated for Discard From Patients With Chronic Heart Disease
Lead sponsor
Cytori Therapeutics
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2013
Completion date
September 30, 2019
Enrollment
20 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure